EMBOLIZATION MARKET ANALYSIS

Embolization Market, By Product Type Particles, Liquid Embolic, Plugs, Coils), By Indication (Hemorrhage/Bleeding, Benign Prostatic Hyperplasia, Uterine Fibroid, Tumor, Malformation (AVM, AVF), Venous embolization, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In February 2024 AI, a leading French expert in medical imaging AI, unveiled a strategic alliance to incorporate its CE-marked CINA-iPE solution into the Blackford AI Platform. This partnership provides healthcare providers with advanced tools to identify incidental pulmonary embolisms more effectively during routine CT scans.
In July 2021, Terumo Medical Corporation, medical technology (TMC) announced the launch of its AZUR Vascular Plug, the first plug compatible with a microcatheter capable of occluding arteries up to 8mm in diameter. This new addition to Terumo's extensive embolization lineup is designed for reducing or halting blood flow in peripheral vasculature arteries.
In April 2021, the US Food and Drug Administration (US FDA) approved Medtronic, medical device company PLC's Pipeline Flex Embolization Device with Shield Technology, primarily indicated for treating brain aneurysms. Shield Technology enhances the flow diverter device by reducing its thrombogenicity, thus improving its performance.
In November 2020 Penumbra, Inc a worldwide healthcare firm emphasizing inventive therapies, has revealed a fresh collaboration with RapidAI. This partnership aims to devise solutions facilitating swifter clinical decisions for diagnosing and treating pulmonary embolism (PE). RapidAI, known for its clinically validated AI platform, enables healthcare providers to enhance diagnostic and treatment decisions promptly and accurately for stroke and aneurysm patients.